◄ back to all posts

ZTS: Zoetis Inc. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 59,990.84
Enterprise Value ($M) 66,038.21
Book Value ($M) 2,185.00
Book Value / Share 4.56
Price / Book 27.57
NCAV ($M) -4,193.00
NCAV / Share -8.74
Price / NCAV -14.37

Profitability (mra)
Return on Invested Capital (ROIC) 0.17
Return on Assets (ROA) 0.17
Return on Equity (ROE) 0.80

Liquidity (mrq)
Quick Ratio 2.46
Current Ratio 3.60

Balance Sheet (mrq) ($M)
Current Assets 4,399.00
Assets 10,777.00
Liabilities 8,592.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5,825.00
Operating Income n/a
Net Income 1,424.00
Earnings Per Share Basic 2.96
Earnings Per Share Diluted 2.93

Cash Flow Statement (mra) ($M)
Cash From Operations 1,790.00
Cash from Investing -2,259.00
Cash from Financing -2,259.00

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-11 13G/A Vanguard Group Inc 7.57 4.74
2019-02-06 13G/A BlackRock Inc. 7.60 -4.66
2018-02-14 13G/A Price T Rowe Associates Inc /md/ 4.70 -44.42
2016-07-08 13D/A Pershing Square Capital Management, L.P. 3.80 -24.35

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-08-09 10-Q/A ZTS / Zoetis Inc. 10-Q/A – Quarterly Report – 10-Q/A
2019-08-06 10-Q ZTS / Zoetis Inc. 10-Q – Quarterly Report – 10-Q
2019-05-02 10-Q ZTS / Zoetis Inc. 10-Q Quarterly Report 10-Q
2019-02-14 10-K ZTS / Zoetis Inc. 10-K (Annual Report)
2018-11-01 10-Q ZTS / Zoetis Inc. 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
PFE – Pfizer, Inc. PRGO – Perrigo Company plc
USNA – USANA Health Sciences, Inc.


Financial data and stock pages provided for FREE by
Fintel.io




2018/07/06
◄ back to all posts
401 K